Analysis of placental growth factor in placentas of normal pregnant women and women with hypertensive disorders of pregnancy

Abstract

To investigate the expressions of placental growth factor (PLGF) in placenta with hypertensive disorders of pregnancy (HDP), 45 women with HDP and 20 normally pregnant women were studied. Among 45 women with HDP, there were 23 cases of severe preeclampsia and one case of eclampsia. The location and level of PLGF proteins was determined by immunohistochemistry and Western blot. The expression of PLGF mRNA in placenta was assessed by reverse transcriptional-polymerase chain reaction (RT-PCR). The results showed that: (1) The distribution of PLGF in placenta with HDP was similar to normal one, which was mainly in the cytoplasm of villous syncytiotrophoblast and villous stroma; (2) The expression of PLGF protein was significantly decreased in placentas with mild and severe preeclampsia compared to the normal ones (0.3±0.4 vs 0.6±0.4, 0.2±0.5 vs 0.6±0.4,P<0.01). There were no differences between the gestational, hypertension placenta and normal one (0.5±0.6 vs 0.6±0.4,P>0.05); (3) The transcription levels of the PLGF mRNA in placentas with preeclampsia were significantly lower than in normal groups (3.33±0.39 vs 4.87±0.60, 1.97±0.29 vs 4.87±0.60,P<0.01), and no differences were found between the gestational hypertension placenta and normal groups. These findings suggest that the abnormal expression of PLGF in placentas is related to the pathogenesis of HDP.

Keywords

placental growth factor / pregnancy complication / hypertension

References

[1] LevineR J, MaynardS E, QianC, et al.. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med, 2004, 350(7): 672-683

[2] TorryD S, WangH S, WangT H, et al.. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol, 1998, 179(6 Pt1): 1539-1544

[3] IyerS, LeonidasD D, SwaminathanG J, et al.. The crystal structure of human placenta growth factor-1 (PGF-1), an angiogenic protein, at 2. 0 A resolution. J Biol Chem, 2001, 276: 12153-12161

[4] ShibuyaM. Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1). Int J Biochem Cell Biol, 2001, 33: 409-420

[5] ShoreV H, WangT H, WangC L, et al.. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta, 1997, 18: 657-665

[6] IshidaA, MurrayJ, SaitoY, et al.. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol, 2001, 188: 359-368

[7] BarleonB, SozzaniS, ZhouD, et al.. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor Flt-1. Blood, 1996, 87: 3336-3343

[8] ZicheM, MaglioneD, RibattiD, et al.. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest, 1997, 76: 517-531

[9] CaoY, ChenH, ZhouL, et al.. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J Biol Chem, 1996, 271: 3154-3162

[10] ZhouY, McMasterM, WooK, et al.. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol, 2002, 160: 1405-1423

[11] AthanassiadesA, LalaP K. Role of placenta growth factor (PLGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta, 1998, 19: 465-473

[12] ShenH L, ChenH P. Progress in study on molecular features of placental growth factor and its receptor and their significance in obstetrical field. Foreign Med Sci Sect Matern Child Health (Chinese), 2004, 15: 298-300

[13] KhaliqA, LiX F, ShamsM, et al.. Localization of placenta growth factor (PLGF) in human term placenta. Growth Factors, 1996, 13: 243-250